Providers' Page

COVID-19 Vaccination Provider Support

 

Vaccination Provider Guidance and Resources:

CDC COVID-19 Vaccination Program Provider Requirements and Support

COVID-19 Vaccine Recommendations

Information on Phased Priority Populations

Clinical Considerations (CDC Interim Guidance) 

 

Moderna COVID-19 Vaccine

EUA for Healthcare Providers

Moderna COVID-19 Vaccine Preparation and Administration

Moderna COVID-19 Vaccine Product Information

 

Pfizer-BioNTech COVID-19 Vaccine

EUA for Healthcare Providers

EUA for Recipients and Caregivers

Safety Information for Healthcare Professionals

Pfizer BioNTech COVID-19 Vaccine Product Information

Pfizer COVID-19 Vaccine Standing Order [PDF]

Pre-Vaccination Screening Form [PDF]

 

Johnson & Johnson (Janssen) COVID-19 Vaccine

EUA for Healthcare Providers

EUA for Recipients and Caregivers

CDPH Statement on Approval to Resume Use of Johnson & Johnson Vaccine 

 

Storage and Handling Guidance

Storage and Handling Guidance - Pfizer

Storage and Handling Toolkit

Storage and Handling Guidance - Moderna

Storage and Handling Guidance - Johnson&Johnson (Janssen)

 

Vaccine Administration Enrollement, Documentation, and ReportingReporting Requirements

 

Preparing to Provide COVID-19 Vaccine to Patients

Centers for Disease Control and Prevention (CDC) Interim Playbook for Jurisdiction Operations        

 CDC Vaccination Playbook Supplement #1

COVID-19 Vaccination Communication Toolkit for Providers 

CMS Toolkit

 

Training and Education: 

COVID Vaccination Educational Brief [Powerpoint]

Training – Immunization Branch

Training and Educational Materials for Healthcare Professionals

 

 Emergency Use Authorizations (EUA) 

 EUA Main Page

About EUAs

 

Talking to Patients About COVID-19 Vaccines: 

 

 

___________________________________________________________________________________________________________________



 

 

 

COVID-19 Guidance: 

CMR 110 D (for reporting COVID-19) 

Specimen Collection Field Guide for COVID-19 testing 

Collection of laboratory specimens for 2019-nCoV testing

Updates in Criteria for Evaluation of PUI

Interim Healthcare Infection Prevention and Control Recommendations for Patients Under Investigation for 2019-nCoV

Laboratory Biosafety Guidelines

 

Communicable Disease:

Measles Clinical Guidance

Measles Information Poster for Office Settings

Title 17, California Code of Regulations, Reportable Diseases & Conditions

 

Forms:

Animal Bite Form

CMR 110 A Form (General report form)

CMR 110 B Form (For tuberculosis only)

CMR 110 C Form (For conditions that impair vehicle driving ability)

Communicable Disease Control Forms

 

General:

CDPH